Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2023-06-01 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Avacta acquires Coris Bioconcept
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the Regulatory Information Service (RNS). The content details a significant corporate action: the acquisition of Coris Bioconcept by Avacta Group plc. This type of announcement, which details a merger or takeover proposal/completion, directly aligns with the definition for M&A Activity (TAR). Although it is distributed via RNS, the core subject matter is M&A, making TAR the most specific classification. The document is substantial (9416 chars) and contains the full details of the transaction, not just a notice that a report is attached, thus ruling out RPA or RNS as the primary classification.
2023-06-01 English
Block Listing Six Monthly Return
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 6112X' and is dated '27 April 2023'. The content details a 'Block Listing Six Monthly Return' for Avacta Group plc, providing updates on unallotted securities under the EMI scheme and LTIP scheme, covering the period from October 2022 to April 2023. This type of periodic filing related to share schemes and AIM compliance, distributed via RNS (Regulatory News Service), is a standard regulatory announcement. Since it is not a full annual report (10-K), an earnings release (ER), or a specific capital change announcement (like SHA or POS), but rather a routine compliance update distributed through the official news service, it best fits the general 'Regulatory Filings' category (RNS) or potentially a specific capital/financing update (CAP) if the focus was purely on the block listing increase. However, given the structure and the explicit mention of RNS distribution and compliance with AIM Rules, RNS is the most appropriate general regulatory classification for this type of routine disclosure that doesn't fit a more specific financial report category. It is not an announcement *about* a report, but the report itself, making RPA less likely than RNS.
2023-04-27 English
First Patient Dosed in the US in AVA6000 Phase 1
Legal Proceedings Report Classification · 99% confidence The document starts with 'RNS Number' and contains information typical of a regulatory news service announcement from the London Stock Exchange (LSE). The content announces a specific corporate event: 'First Patient Dosed in the US in Avacta's AVA6000 Phase 1 Clinical Study'. This is a material, time-sensitive update that is being disseminated via the RNS system. Since it is a general announcement of a significant corporate event (clinical trial milestone) that doesn't fit into the more specific categories like ER, CT, or CAP, and it is clearly distributed through the official regulatory news service, the most appropriate classification is Regulatory Filings (RNS). The document length (6121 chars) is substantial enough that it is the announcement itself, not just a brief notice pointing to another document.
2023-04-27 English
Preliminary Results
Earnings Release Classification · 100% confidence The document explicitly states: 'Avacta Group plc... is pleased to announce its unaudited preliminary results for the year ended 31 December 2022.' It contains detailed financial highlights (Revenues, EBITDA loss, Operating loss, EPS) and operational reviews for the full year, which are characteristic of an Annual Report. However, the filing is presented as an RNS announcement (RNS Number : 2982X) and is titled 'Preliminary Results for the year ended 31 December 2022'. In the context of US SEC filings, preliminary results often precede the full 10-K filing, but for general corporate filings, a comprehensive annual results announcement that is not explicitly labeled '10-K' but covers the full fiscal year is best classified as an Annual Report (AR) if it contains the full financial details, or potentially an Earnings Release (ER) if it were just highlights. Given the depth of financial figures and the full-year scope, it strongly suggests the content of an Annual Report. Since the document is presented via RNS, it is a regulatory announcement of the annual results. If '10-K' is reserved strictly for the SEC filing, 'AR' (Audit Report / Information) is the closest fit for comprehensive annual results information, although 'ER' (Earnings Release) is also plausible if this is the initial summary. Given the detailed financial tables and management commentary covering the entire year, it goes beyond a typical 'ER' (which is usually just key highlights). Since the definition for 'AR' is 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)', and this document *is* the full annual result announcement, it is slightly ambiguous. However, in many non-US contexts, the preliminary results announcement serves as the primary annual report disclosure. Given the comprehensive nature covering the full year ended Dec 31, 2022, and the inclusion of detailed financial metrics, it is most accurately classified as the Annual Report content, even if delivered via RNS. If the document were significantly shorter and only pointed to the full report, it would be RPA/RNS. Since the full results are detailed here, I classify it as AR, recognizing the overlap with ER/RPA due to the RNS wrapper. FY 2022
2023-04-25 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change Classification · 99% confidence The document is an RNS announcement dated April 21, 2023, titled 'Issue of Equity and Total Voting Rights'. It details the allotment of 2,906,097 new ordinary shares to settle a convertible bond repayment. This action directly relates to changes in the company's share capital structure and total voting rights. This fits the definition of 'Share Issue/Capital Change' (SHA). While it is distributed via RNS, the core subject matter is a specific capital event, making SHA a more precise classification than the general fallback RNS.
2023-04-21 English
AVA3996 data poster presented at AACR
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number' and is dated April 17, 2023. It announces that Avacta Group PLC presented pre-clinical data at the AACR Meeting and that the poster and explanatory video are now available on the Company's website. The structure, use of RNS numbering, and the nature of the announcement (providing updates on research progress and directing users to where the detailed information/presentation can be found) strongly suggest this is a general regulatory announcement rather than a full financial report (like 10-K or IR) or a specific investor presentation (IP). Since it is a formal announcement distributed via RNS, and it doesn't fit neatly into the other specific categories (like Director's Dealing, Dividend Notice, or Earnings Release), the most appropriate classification is the general regulatory filing category.
2023-04-17 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.